Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 10:38 AM

Published 11/06/2009 by World Pharma News


Pfizer and Medivation Initiate Two Phase 3 Trials of Dimebon

Pfizer Inc (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) announced the initiation of CONTACT and CONSTELLATION, two Phase 3 trials of the investigational drug dimebon (latrepirdine)* in patients with moderate-to-severe Alzheimer's disease (AD).

The CONTACT study will assess as primary endpoints the potential...

Share this 

What others report on the same story

Pfizer, Medivation begin 2 phase-3 trial of dru...
Pfizer Inc and Medivation, Inc announced the initiation of Contact and Constellation, two phase-3 trials of the investigational drug dimebon (latrepirdine) in patients ... - [11/05/2009 - PharmaBiz]

Related Stories

First Reported 11/09/2009 - Updated 11/10/2009 - 37 Documents
Wyeth Ltd - Click to view image in its original context
Wyeth Ltd
Pfizer will shut down six research-and-development sites in the U.S. and the U.K. as it streamlines R&D operations under a merger with Wyeth. The move will result in job cuts, including 600 employees at Pfizer's facility in St. Louis.St. Louis Post-Dispatch| ... [SmartBrief - 11/10/2009]
First Reported 11/09/2009 - Updated 11/10/2009 - 12 Documents (in Biotechnology)
Monsanto Company - Click to view image in its original context
Monsanto Company
Twenty-five years ago, fast-growing Monsanto Co. christened a new research campus in Chesterfield.On Monday, a reincarnation of the same company reclaimed the property for $435 million.Monsanto's plans to buy the Chesterfield Village Research Center from ... [Individual.com - 11/10/2009]
First Reported 11/13/2009 - Updated 11/13/2009 - 5 Documents
Well looks like the entire town of New London, Conn. is going to get screwed by Pfizer. “Look what they did,” Mr. Cristofaro said on Thursday. “They stole our home for economic development. It was all for Pfizer, and now they get up and walk away.” That ... [Outside The Beltway | OTB - 11/13/2009]
First Reported 11/11/2009 - Updated 11/12/2009 - 4 Documents (in Health)
WASHINGTON -- John J. O'Connor III, the husband of retired Supreme Court Justice Sandra Day O'Connor, has died.The court said that O'Connor, 79, died Wednesday in Phoenix, Ariz., of complications arising from Alzheimer's disease.John O'Connor, himself ... [NewsMax.com - 11/12/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 5 Documents (in Health)
Pfizer Inc - Click to view image in its original context
Pfizer Inc
The boss of the new HIV company set up by GlaxoSmithKline and Pfizer has said it will be "up to the shareholders" to decide whether the business eventually spins off and floats. By Graham Ruddick Published: 7:14PM GMT 03 Nov 2009 ViiV Healthcare, which ... [Telegraph - 11/03/2009]
Entities: HIV/AIDS, Pfizer Inc, Limet, IPO
First Reported 11/05/2009 - Updated 11/05/2009 - 4 Documents (in Medicine)
GlaxoSmithKline, a UK-based pharmaceutical group, and Pfizer, a US-based pharmaceutical group, have launched ViiV Healthcare, a new specialist HIV company.ViiV Healthcare has 10 medicines currently available including therapies such as Epzicom/Kivexa ... [Individual.com - 11/05/2009]
First Reported 11/10/2009 - Updated 11/10/2009 - 3 Documents
(RTTNews) - Tuesday, Pfizer China, a unit of drug maker Pfizer Inc (PFE: News ), said it entered into a partnership with China's BMP Sunstone Corp. (BJGP) to exclusively import, distribute and promote Depo-Provera or Medroxy-progesterone Acetate, a Pfizer ... [RTTNews.com - 11/10/2009]
First Reported 11/04/2009 - Updated 11/04/2009 - 2 Documents (in Health)
The joint venture between , Viiv, has officially opened up for business as a powerhouse developer of new HIV therapies. But analysts are wondering if Viiv has more to do with getting the two pharma giants out of the controversial therapeutic area than ... [FierceBiotech - 11/04/2009]
First Reported 11/04/2009 - Updated 11/04/2009 - 1 Documents (in Corporate Deals)
Merck & Co. led drug stocks higher early Wednesday, as the pharmaceutical giant marked the first day since the closure of its $41 billion merger with rival Schering-Plough Corp.The NYSE Arca Pharmaceutical Index rose 0.5% to 286.64, and the NYSE Arca ... [MarketWatch - 11/04/2009]
Network

Blogs

sort by: Date | Relevance
Pfizer's Site Closures - An Analysis [Corante - 11/11/2009]
Pharmaconduct.org has another look at Pfizer's announcement yesterday, and tries to address some of the many unanswered questions left open by the company's press ...
Pfizer's Chemistry Head Count - Really? [Corante - 11/12/2009]
A reader who's (unfortunately) in a position to know the details sends along some numbers on Pfizer's chemistry shakeout. According to his figures, Pfizer (pre-Wyeth ...
Pfizer's New Layout [Corante - 11/10/2009]
The company has issued a press release detailed which sites are staying, and which are leaving: Pfizer will have five main research sites that will serve as central ...
Pfizer, Then and Now: Shareholder Say On Execut... [WSJ.com: Health Blog - 10/30/2009]
Pfizer shareholders will get to cast a non-binding “advisory vote” on the company’s compensation packages for senior execs. In its press release announcing the news ...
Another Look at Pfizer's Recent Moves [Healthcare Sector and Stocks Analysis from Seek ... - 11/10/2009]
Derek Lowe submits: Pharmaconduct.org has another look at Pfizer's (PFE) announcement Monday, and tries to address some of the many unanswered questions left open ...
1 2 3 4 5 6 7 8 9 10

Audio/Video

sort by: Date | Relevance
Pfizer Broke Law by Promoting Drugs for Unappro... [Bloomberg - YouTube - 11/09/2009]
Dementia drugs have 'modest impact' [ITN News - YouTube - 11/12/2009]
1

  •  
  •  
  •